Asthma Asthma  In adults who have stable asthma while they are taking a combination of LABA and inhaled corticosteroids , stopping LABA may increase the risk of asthma exacerbations that require treatment with corticosteroids by mouth.  Stopping LABA probably makes little or no important difference to asthma control or asthma-related quality of life.  Whether or not stopping LABA increases the risk of serious adverse events or exacerbations requiring an emergency department visit or hospitalisation is uncertain. Medications are typically provided as metered-dose inhalers  in combination with an asthma spacer or as a dry powder inhaler.  The spacer is a plastic cylinder that mixes the medication with air, making it easier to receive a full dose of the drug.  A nebulizer may also be used.  Nebulizers and spacers are equally effective in those with mild to moderate symptoms Asthma Asthma